Ozempic

Indicated For

Type 2 Diabetes Mellitus, cardiovascular risk reduction

About This Medication

# Ozempic (Semaglutide) Patient Assistance Program Guide ## Who Qualifies for the Novo Nordisk Patient Assistance Program (PAP)? If you need Ozempic but cannot afford it, the **Novo Nordisk Patient Assistance Program (PAP)** may be able to provide it to you at no cost. This program is designed for people who meet specific income and insurance requirements. For a single person, your annual household income must be at or below **$60,240** to qualify. In terms of insurance, you must be uninsured or have Medicare Part D — if you have commercial (private) insurance that covers Ozempic, you are generally not eligible for this program, though a separate savings card option may be available to you. Patients who receive Medicaid, the Low Income Subsidy (LIS), or VA benefits are also not eligible. If you meet these basic criteria, you may qualify to receive Ozempic at no charge, shipped directly to your home. --- ## About Ozempic (Semaglutide) Ozempic (semaglutide) is a prescription injectable medication approved by the FDA to treat **Type 2 Diabetes Mellitus** in adults. It also carries an FDA approval to reduce the risk of serious cardiovascular events — such as heart attack or stroke — in adults with Type 2 diabetes who also have established heart disease. Ozempic belongs to a drug class called **GLP-1 receptor agonists**, which work by targeting specific receptors involved in blood sugar regulation. Without insurance or assistance, Ozempic can cost well over $900 per month at retail prices, making it unaffordable for many patients. The Novo Nordisk PAP exists specifically to help bridge that gap for people who qualify. --- ## Income Eligibility: Full Breakdown The Novo Nordisk PAP uses income limits based on **400% of the Federal Poverty Level (FPL)**. Your total household income must fall at or below the threshold for your household size. Here is a full breakdown: | Household Size | Maximum Annual Income | |---|---| | 1 person | $60,240 | | 2 persons | $81,760 | | 3 persons | $103,280 | | 4 persons | $124,800 | If your household has more than four people, the income limit increases with each additional member. If your income is above these limits, you may still want to apply — some programs allow for special consideration based on high medical expenses or other financial hardships, though this is not guaranteed. Your income is typically verified using your **most recent federal 1040 tax return**. If you have not yet filed or your income has recently changed, three months of recent pay stubs may also be accepted. It is important to report your full household income, including wages, retirement benefits, Social Security, and any other regular sources of income. Medicare Part D patients may be subject to specific additional provisions that differ from standard income rules. --- ## Insurance Requirements Explained Understanding your insurance situation is key before you apply. Here is how different coverage types are handled: - **If you are uninsured:** You are likely eligible for the PAP, provided you meet income requirements. This is the primary population the program is designed to serve. - **If you have Medicare Part D:** You may still qualify for the PAP. Novo Nordisk makes specific provisions for Medicare Part D patients, though additional eligibility rules apply. You must not also be receiving the Low Income Subsidy (LIS), as that disqualifies you. - **If you have private (commercial) insurance:** You are generally **not eligible** for the PAP, even if your plan covers Ozempic poorly. However, Novo Nordisk offers a separate **savings card** for commercially insured patients that may significantly reduce your out-of-pocket costs. - **If you have Medicaid:** You do **not** qualify for the PAP. Similarly, patients receiving VA benefits are excluded. These programs are considered existing forms of prescription assistance and make you ineligible. --- ## Step-by-Step: How to Apply Follow these steps to apply for the Novo Nordisk PAP for Ozempic: 1. **Check your eligibility first.** Review the income table and insurance requirements above to confirm you likely qualify before gathering documents. 2. **Gather your required documents.** You will need: - A completed and signed PAP application - Proof of income (typically your most recent federal 1040 tax return) - A valid prescription for Ozempic from your healthcare provider 3. **Get your application.** Visit the official program page at [https://www.novocare.com/diabetes/help-affording-medication/pap.html](https://www.novocare.com/diabetes/help-affording-medication/pap.html) to apply online or download a paper application. You can also call **(866) 310-7549** to request an application by phone. 4. **Have your doctor sign the application.** Most PAP applications require a healthcare provider signature in addition to your own. Confirm this with your doctor's office before submitting. 5. **Submit your application.** You may submit online through the NovoCare portal, or send your completed application and documents by fax to **(866) 441-4190**. Keep copies of everything you send. 6. **Wait for confirmation.** Processing typically takes **7 to 10 business days** after Novo Nordisk receives your complete application. 7. **Watch for your approval notice.** Once approved, you will receive confirmation and your medication will be shipped directly to your home address. --- ## What to Expect: Timeline and Delivery After you submit a complete application — including all required documents and your doctor's signature — processing typically takes **7 to 10 business days**. Novo Nordisk or the program administrator will notify you of your approval status. If approved, your Ozempic will be **shipped directly to your home address**, so there is nothing you need to pick up at a pharmacy. You do not need to do anything at the point of delivery other than receive the package. PAP enrollment is not permanent. You will need to **reauthorize your enrollment annually** to continue receiving medication. Novo Nordisk will typically notify you when it is time to renew, but it is a good idea to track your enrollment date and begin the renewal process early to avoid any gaps in your supply. --- ## Alternatives If You Don't Qualify If you do not qualify for the Novo Nordisk PAP, there are still options worth exploring: 1. **Biosimilars:** There are currently **no FDA-approved biosimilar alternatives** to Ozempic (semaglutide) available in the United States. This may change in the future, but no substitutes are currently on the market. 2. **Manufacturer savings card:** If you have commercial insurance, Novo Nordisk offers an Ozempic savings card that may lower your monthly cost. Visit [https://www.ozempic.com/savings-and-resources/save-on-ozempic.html](https://www.ozempic.com/savings-and-resources/save-on-ozempic.html) to learn more and enroll. 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states offer their own prescription assistance programs, particularly for seniors and people with disabilities. Eligibility and benefits vary by state. 4. **NeedyMeds.org:** This free, independent database lists hundreds of patient assistance programs, drug discount cards, and state-level programs. It is a useful tool if you need to explore multiple options at once. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novo Nordisk. Program terms may change — verify current requirements at [https://www.novocare.com/diabetes/products/ozempic/let-us-help/pap.html](https://www.novocare.com/diabetes/products/ozempic/let-us-help/pap.html) before applying.* ---

Program information last verified: February 27, 2026